Cytokine Blockade of HIV-1 Replication

Skolnik, Paul R.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Allergy and Infectious Diseases (NIAID)
• Type: Research Project (R01)
• Project #: 5R01AI033290-03
• Application #: 2068279
• Study Section: AIDS and Related Research Study Section 1 (ARRA)
• Project Start: 1993-04-01
• Project End: 1997-03-31
• Budget Start: 1995-04-01
• Budget End: 1997-03-31
• Support Year: 3
• Fiscal Year: 1995

Institution

• Name: Tufts University
• City: Boston
• State: MA
• Country: United States
• Zip Code: 02111

Publications

Ioannidis, J P; Cappelleri, J C; Lau, J et al. (1996) Predictive value of viral load measurements in asymptomatic untreated HIV-1 infection: a mathematical model. AIDS 10:255-62

Perales, M A; Skolnik, P R; Lieberman, J (1996) Effect of interleukin 12 on in vitro HIV type 1 replication depends on clinical stage. AIDS Res Hum Retroviruses 12:659-68

Angel, J B; Saget, B M; Wang, M Z et al. (1995) Interleukin-10 enhances human immunodeficiency virus type 1 expression in a chronically infected promonocytic cell line (U1) by a tumor necrosis factor alpha-independent mechanism. J Interferon Cytokine Res 15:575-84

Angel, J B; Saget, B M; Walsh, S P et al. (1995) Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication. AIDS 9:1137-44

Ioannidis, J P; Reichlin, S; Skolnik, P R (1995) Long-term productive human immunodeficiency virus-1 infection in human infant microglia. Am J Pathol 147:1200-6